Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …

Uric acid is the final oxidation product of purine metabolism in humans. Xanthine
oxidoreductase (XOR) catalyzes oxidative hydroxylation of hypoxanthine to xanthine to uric …

Xanthine oxidase, a molybdo-flavoenzyme, and an isoform of xanthine dehydrogenase both
exist as xanthine oxidoreductase and are responsible for purine catabolism. Xanthine …

Xanthine oxidase (XO), a versatile metalloflavoprotein enzyme, catalyzes the oxidative
hydroxylation of hypoxanthine and xanthine to uric acid in purine catabolism while …

Almost all drug molecules become the substrates for oxidoreductase enzymes, get
metabolized into more hydrophilic products and eliminated from the body. These …

Xanthine oxidase (XO) is the enzyme responsible for the catabolism of purines and their
conversion into uric acid. XO is thus the target for the treatment of hyperuricemia and gout …

Microwave-assisted (MWA) multicomponent reactions (MCRs) have successfully emerged
as one of the useful tools in the synthesis of biologically relevant heterocycles. These …

Introduction Xanthine oxidase (XO) is a molybdoflavoprotein that catalyzes the oxidative
hydroxylation of purines to produce uric acid and reactive oxygen species. These reaction …

Introduction: Xanthine oxidase (XO) is a versatile molybdoflavoprotein, widely distributed,
occurring in milk, kidney, lung, heart, and vascular endothelium. Catalysis by XO to produce …

Xanthine oxidoreductase (XOR), which is widely distributed from humans to bacteria, has a
key role in purine catabolism, catalyzing two steps of sequential hydroxylation from …